CR6709A - Agentes antibacteriales 3-aminiquinazolin-2,4-diona - Google Patents

Agentes antibacteriales 3-aminiquinazolin-2,4-diona

Info

Publication number
CR6709A
CR6709A CR6709A CR6709A CR6709A CR 6709 A CR6709 A CR 6709A CR 6709 A CR6709 A CR 6709A CR 6709 A CR6709 A CR 6709A CR 6709 A CR6709 A CR 6709A
Authority
CR
Costa Rica
Prior art keywords
aminiquinazolin
diona
antibacterial agents
substituted
heteroarilo
Prior art date
Application number
CR6709A
Other languages
English (en)
Inventor
Lee Ellsworth Edmund
Bird Paul
Quoc Nguyen Dai
Peter Sanchez Joseph
Daniel Hollis Showalter Howard
Singh Rajeshwar
Andrew Stier Michael
Phong Tran Tuan
Morgan Watson Brian
Yip Judy
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of CR6709A publication Critical patent/CR6709A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Paper (AREA)

Abstract

UN COMPUESTO DE FORMULA I O UNA SAL FARMACEUTICAMENTE ACEPTABLE CORRESPONDIENTE DONDE R1 Y R3 SON INDEPENDIENTEMENTE H , C1-C12 ALQUILO O ALQUILO SUSTITUIDO, C2-C12 ALQUENILO O ALQUENILO SUSTITUIDO, C3-C12 CICLOALQUILO O CICLOALQUILO SUSTITUIDO, ARILO Y ARILO SUSTITUIDO, HETEROCICLICO Y HETEROCICLICO SUSTITUDO, HETEROARILO Y HETEROARILO SUSTITUIDO, R5, R6 Y R8 SON INDEPENDIENTEMENTE H.
CR6709A 2000-01-24 2002-07-19 Agentes antibacteriales 3-aminiquinazolin-2,4-diona CR6709A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US24126700P 2000-10-18 2000-10-18

Publications (1)

Publication Number Publication Date
CR6709A true CR6709A (es) 2003-11-25

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6709A CR6709A (es) 2000-01-24 2002-07-19 Agentes antibacteriales 3-aminiquinazolin-2,4-diona

Country Status (38)

Country Link
US (2) US7094780B1 (es)
EP (1) EP1255739B1 (es)
JP (1) JP4811978B2 (es)
KR (1) KR20020067701A (es)
CN (1) CN1425008A (es)
AP (1) AP2002002603A0 (es)
AR (1) AR030186A1 (es)
AT (1) ATE398110T1 (es)
AU (1) AU783078B2 (es)
BG (1) BG107023A (es)
BR (1) BR0017010A (es)
CA (1) CA2393802C (es)
CO (1) CO5320600A1 (es)
CR (1) CR6709A (es)
DE (1) DE60039194D1 (es)
EA (1) EA005585B1 (es)
EE (1) EE200200412A (es)
ES (1) ES2304992T3 (es)
GE (1) GEP20053429B (es)
HK (1) HK1054237A1 (es)
HN (1) HN2001000009A (es)
HR (1) HRP20020696A2 (es)
HU (1) HUP0204101A3 (es)
IL (1) IL150393A0 (es)
IS (1) IS6448A (es)
MA (1) MA26866A1 (es)
MX (1) MXPA02005989A (es)
NO (1) NO20023516D0 (es)
OA (1) OA12316A (es)
PA (1) PA8510101A1 (es)
PE (1) PE20011060A1 (es)
PL (1) PL356837A1 (es)
SK (1) SK10572002A3 (es)
SV (1) SV2001000288A (es)
TN (1) TNSN01011A1 (es)
UY (1) UY26551A1 (es)
WO (1) WO2001053273A1 (es)
YU (1) YU55902A (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812644B1 (pt) 1997-09-15 2010-07-13 quinolonas antimicrobianas, composição farmacêutica e uso das mesmas.
MXPA03010799A (es) 2001-05-30 2005-07-25 Warner Lambert Co Agentes antibacterianos.
BR0210028A (pt) * 2001-06-19 2004-06-22 Warner Lambert Co Agentes antibacterianos
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
BRPI0414319A (pt) * 2003-09-12 2006-11-07 Warner Lambert Co agentes antibacterianos de quinolona
JP2007511597A (ja) * 2003-11-18 2007-05-10 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌アミノキナゾリヂンヂオン誘導体
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
ATE447572T1 (de) * 2005-01-26 2009-11-15 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
EP1999125A2 (en) 2006-03-28 2008-12-10 The Procter and Gamble Company A coupling process for preparing quinolone intermediates
ATE507219T1 (de) 2006-03-28 2011-05-15 Warner Chilcott Co Llc Malatsalze und polymorphe von (3s,5s)-7-ä3-amino- 5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro 8-methoxy-4-oxo-3-chinolincarbonsäure
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
PL2239257T3 (pl) * 2008-01-30 2012-10-31 Shin Poong Pharmaceutical Co Ltd Nowe pochodne chinazolino-2,4-dionu oraz zawierające je farmaceutyczne kompozycje do profilaktyki i leczenia chorób nerwów czaszkowych
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
KR102132574B1 (ko) 2011-03-15 2020-07-09 로렌스 리버모어 내쇼날 시큐리티, 엘엘시 트라이사이클릭 자이라제 억제제
RS57621B1 (sr) * 2011-12-21 2018-11-30 Jiangsu Hengrui Medicine Co Derivat šestočlanog heteroaril prstena pirola, postupak njegove pripreme i njegova medicinska upotreba
SG10201610416TA (en) 2012-06-13 2017-01-27 Incyte Corp Substituted tricyclic compounds as fgfr inhibitors
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
EP2895488A1 (en) 2012-09-12 2015-07-22 Trius Therapeutics, Inc. Tricyclic gyrase inhibitors for use as antibacterial agents
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
SI2986610T1 (en) 2013-04-19 2018-04-30 Incyte Holdings Corporation Bicyclic heterocycles as inhibitors of FGFR
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MX2020004108A (es) 2015-02-20 2022-01-03 Incyte Corp Heterociclos biciclicos como inhibidores de receptores del factor de crecimiento fibroblastico (fgfr).
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
WO2019213544A2 (en) 2018-05-04 2019-11-07 Incyte Corporation Solid forms of an fgfr inhibitor and processes for preparing the same
TW201946630A (zh) 2018-05-04 2019-12-16 美商英塞特公司 Fgfr抑制劑之鹽
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
IL291901A (en) 2019-10-14 2022-06-01 Incyte Corp Bicyclyl heterocycles as fgr suppressors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021113462A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Derivatives of an fgfr inhibitor
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (es) * 1959-11-05
NL80851C (es) * 1958-02-25 1956-03-15
ATE8626T1 (de) 1980-03-10 1984-08-15 Berri-Balzac Societe Dite: 3-amino-(1h,3h)-2,4-chinazolindionderivate.
GB2097784A (en) 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
AU5813394A (en) 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
AU6908398A (en) 1996-10-28 1998-05-22 Versicor Inc Fused 2,4-pyrimidinedione combinatorial libraries and biologically active fused 2,4-pyramidinediones
US6331538B1 (en) * 1997-10-28 2001-12-18 Warner-Lambert Company 7-substituted quinazolin-2,4-diones useful as antibacterial agents
EP1080092B1 (en) 1998-05-26 2008-07-23 Warner-Lambert Company LLC Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
WO2000035885A1 (en) * 1998-12-11 2000-06-22 F. Hoffmann-La Roche Ag Cyclic hydrazine derivatives as tnf-alpha inhibitors

Also Published As

Publication number Publication date
CA2393802C (en) 2011-04-19
CO5320600A1 (es) 2003-09-30
ATE398110T1 (de) 2008-07-15
EA005585B1 (ru) 2005-04-28
US20060183762A1 (en) 2006-08-17
HUP0204101A2 (hu) 2003-04-28
IS6448A (is) 2002-06-27
JP2003520277A (ja) 2003-07-02
HK1054237A1 (zh) 2003-11-21
PE20011060A1 (es) 2001-10-12
PL356837A1 (en) 2004-07-12
NO20023516L (no) 2002-07-23
AR030186A1 (es) 2003-08-13
MA26866A1 (fr) 2004-12-20
HUP0204101A3 (en) 2004-05-28
YU55902A (sh) 2006-01-16
EP1255739A1 (en) 2002-11-13
US7582627B2 (en) 2009-09-01
IL150393A0 (en) 2002-12-01
OA12316A (en) 2006-05-15
SV2001000288A (es) 2001-11-30
AU783078B2 (en) 2005-09-22
CA2393802A1 (en) 2001-07-26
GEP20053429B (en) 2005-01-25
HRP20020696A2 (en) 2003-12-31
EA200200661A1 (ru) 2003-02-27
US7094780B1 (en) 2006-08-22
PA8510101A1 (es) 2003-06-30
KR20020067701A (ko) 2002-08-23
EE200200412A (et) 2003-10-15
BG107023A (en) 2003-04-30
NO20023516D0 (no) 2002-07-23
EP1255739B1 (en) 2008-06-11
CN1425008A (zh) 2003-06-18
HN2001000009A (es) 2001-06-13
WO2001053273A1 (en) 2001-07-26
DE60039194D1 (de) 2008-07-24
SK10572002A3 (sk) 2003-10-07
ES2304992T3 (es) 2008-11-01
AU2089901A (en) 2001-07-31
US20060287308A1 (en) 2006-12-21
TNSN01011A1 (en) 2005-11-10
UY26551A1 (es) 2001-04-30
AP2002002603A0 (en) 2002-09-30
JP4811978B2 (ja) 2011-11-09
BR0017010A (pt) 2002-11-05
MXPA02005989A (es) 2002-10-23

Similar Documents

Publication Publication Date Title
CR6709A (es) Agentes antibacteriales 3-aminiquinazolin-2,4-diona
NO20060219L (no) Forbindelser
HN2002000028A (es) Pirimidinas inhibidoras de metaloproteinasas
EA200400893A1 (ru) N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
AR028706A1 (es) Tiazina oxazolidinona
SE0000540D0 (sv) New compounds
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
NO995846D0 (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
NO20012567L (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20023456L (no) Nitrogenholdige forbindelser og farmasöytiske preparater inneholdende de samme
AR024077A1 (es) Compuestos antibacterianos
ES2186916T3 (es) Derivados de isoxazolina como agentes antimicrobianos.
ATE271868T1 (de) Neue cathechole als antimikrobielle mittel
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
DE60014143D1 (de) Antimikrobielle 4-oxochinolizine mit 2-pyridongerüsten als teilstruktur
CO5640079A2 (es) Nuevos bioisosteros de actinonina
DE60324685D1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin-wiederaufnahme-inhibitoren
ATE428420T1 (de) Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer
RS52427B (en) ANTIBIOTIC 107891, ITS FACTORS, PHARMACEUTICALALLY ACCEPTABLE SALTS AND MIXTURES, AND THEIR USE
NO20025659L (no) Heterocykliske forbindelser
DK1159258T3 (da) Amidforbindelser til potensering af kolinerg aktivitet
DK1223935T3 (da) Anvendelse af gemifloxacinforbindelser mod bakterier
DK1338596T3 (da) Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)